FORWARD-LOOKING INFORMATION
We make forward-looking statements herein and will make forward-looking
statements in future filings with the SEC, press releases or other written or
oral communications within the meaning of Section 27A of the Securities Act of
1933, as amended (the "Securities Act"), and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). For these statements, we
claim the protections of the safe harbor for forward-looking statements
contained in such Sections. Forward-looking statements are subject to
substantial risks and uncertainties, many of which are difficult to predict and
are generally beyond our control. These forward-looking statements include
information about possible or assumed future results of our business, financial
condition, liquidity, results of operations, plans and objectives. When we use
the words "believe," "expect," "anticipate," "estimate," "plan," "continue,"
"intend," "should," "may" or similar expressions, it intends to identify
forward-looking statements. Statements regarding the following subjects, among
others, may be forward-looking: the macro- and micro-economic impact of the
COVID-19 pandemic; the severity and duration of the COVID-19 pandemic; actions
taken by governmental authorities to contain the COVID-19 pandemic or treat its
impact; the efficacy of the vaccines or other remedies and the speed of their
distribution and administration; the impact of the COVID-19 pandemic on our
financial condition, results of operations, liquidity and capital resources;
market trends in our industry, interest rates, real estate values, the debt
securities markets or the general economy; the demand for commercial real estate
loans; our business and investment strategy; our operating results; actions and
initiatives of the U.S. government and governments outside of the United States,
changes to government policies and the execution and impact of these actions,
initiatives and policies; the state of the economy generally or in specific
geographic regions; economic trends and economic recoveries; our ability to
obtain and maintain financing arrangements, including secured debt arrangements
and securitizations; the timing and amount of expected future fundings of
unfunded commitments; the availability of debt financing from traditional
lenders; the volume of short-term loan extensions; the demand for new capital to
replace maturing loans; expected leverage; general volatility of the securities
markets in which we participate; changes in the value of our assets; the scope
of our target assets; interest rate mismatches between our target assets and any
borrowings used to fund such assets; changes in interest rates and the market
value of our target assets; changes in prepayment rates on our target assets;
effects of hedging instruments on our target assets; rates of default or
decreased recovery rates on our target assets; the degree to which hedging
strategies may or may not protect us from interest rate volatility; impact of
and changes in governmental regulations, tax law and rates, accounting, legal or
regulatory issues or guidance and similar matters; our continued maintenance of
our qualification as a REIT for U.S. federal income tax purposes; our continued
exclusion from registration under the Investment Company Act of 1940, as amended
(the "1940 Act"); the availability of opportunities to acquire commercial
mortgage-related, real estate-related and other securities; the availability of
qualified personnel; estimates relating to our ability to make distributions to
our stockholders in the future; our present and potential future competition;
and unexpected costs or unexpected liabilities, including those related to
litigation.
The forward-looking statements are based on our beliefs, assumptions and
expectations of our future performance, taking into account all information
currently available to us. Forward-looking statements are not predictions of
future events. These beliefs, assumptions and expectations can change as a
result of many possible events or factors, not all of which are known to us. See
"Item 1A. Risk Factors" of this Quarterly Report on Form 10-Q and our Annual
Report. These and other risks, uncertainties and factors, including those
described in the annual, quarterly and current reports that we file with the
SEC, could cause our actual results to differ materially from those included in
any forward-looking statements we make. All forward-looking statements speak
only as of the date they are made. New risks and uncertainties arise over time
and it is not possible to predict those events or how they may affect us. Except
as required by law, we are not obligated to, and do not intend to, update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise.
Overview
We are a Maryland corporation and have elected to be taxed as a REIT for U.S.
federal income tax purposes. We primarily originate, acquire, invest in and
manage performing commercial first mortgage loans, subordinate financings, and
other commercial real estate-related debt investments. These asset classes are
referred to as our target assets.
We are externally managed and advised by the Manager, an indirect subsidiary of
Apollo, a leading global alternative investment manager with a contrarian and
value-oriented investment approach in private equity, credit and real estate
with assets under management of approximately $455.5 billion as of December 31,
2020.
The Manager is led by an experienced team of senior real estate professionals
who have significant expertise in underwriting and structuring commercial real
estate financing transactions. We benefit from Apollo's global infrastructure
and operating platform, through which we are able to source, evaluate and manage
potential investments in our target assets.
Current Market Conditions


                                       31
--------------------------------------------------------------------------------

During the first quarter of 2020, there was a global outbreak of COVID-19, which
was declared by the World Health Organization as a pandemic. In response to
COVID-19, the United States and numerous other countries declared national
emergencies, which has led to large scale quarantines as well as restrictions to
business deemed non-essential. These responses to COVID-19 have disrupted
economic activities and could have a significant continued adverse effect on
economic and market conditions, and could result in a recession. As we are still
in the midst of the COVID-19 pandemic we are not in a position to estimate the
ultimate impact this will have on our business and the economy as a whole. The
effects of COVID-19 have adversely impacted the value of our assets, business,
financial condition, results of operations and cash flows, and our ability to
operate successfully. Some of the factors that impacted us to date and may
continue to affect us are outlined in "Item 1A. Risk Factors" of our Annual
Report on Form 10-K. Please see "Liquidity and Capital Resources" below for
additional discussion surrounding the ongoing impact we expect COVID-19 will
have on our liquidity and capital resources.
Critical Accounting Policies
A summary of our critical accounting policies is set forth in our Annual Report
under "Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations - Critical Accounting Policies and Use of Estimates."
Results of Operations
All non-USD denominated assets and liabilities are translated to USD at the
exchange rate prevailing at the reporting date and income, expenses, gains, and
losses are translated at the prevailing exchange rate on the dates that they
were recorded.
Loan Portfolio Overview
The following table sets forth certain information regarding our commercial real
estate debt portfolio as of March 31, 2021 ($ in thousands):
                                           Amortized           

Weighted-Average Coupon Weighted Average Secured Debt


                          Equity at
           Description                        Cost                       (1)                     All-in Yield          Arrangements (3)       Cost of Funds           cost(4)
                                                                                                    (1)(2)
Commercial mortgage loans, net           $ 5,754,258                             4.6  %                   5.0  %       $   3,430,379                  2.1  %       $ 2,323,879
Subordinate loans and other                1,065,816                            10.9  %                  12.1  %                   -                    -            1,065,816
lending assets, net
Total/Weighted-Average                   $ 6,820,074                             5.6  %                   6.2  %       $   3,430,379                  2.1  %       $ 3,389,695


-------
(1)  Weighted-Average Coupon and Weighted-Average All-in Yield are based on the
applicable benchmark rates as of March 31, 2021 on the floating rate loans.
(2)   Weighted-Average All-in Yield includes the amortization of deferred
origination fees, loan origination costs and accrual of both extension and exit
fees. Weighted-Average All-in Yield excludes the benefit of forward points on
currency hedges relating to loans denominated in currencies other than USD.
(3)  Gross of deferred financing costs of $11.8 million.
(4)  Represents loan portfolio at amortized cost less secured debt outstanding.
The following table provides details of our commercial mortgage loan portfolio
and subordinate loan and other lending assets portfolio, on a loan-by-loan
basis, as of March 31, 2021 ($ in millions):
Commercial Mortgage Loan Portfolio
                                                                                                                             Construction
   #              Property Type            Risk Rating       Origination Date        Amortized Cost   Unfunded Commitment        Loan          Fully-extended Maturity         Location
1        Urban Retail                           3                 12/2019                 $352                 $-                                      12/2023           London, UK
2        Urban Retail                           3                 08/2019                 317                  -                                       09/2024           Manhattan, NY
3        Hotel                                  3                 10/2019                 267                  46                                      08/2024           Various
4        Office                                 3                 02/2020                 231                  -                                       02/2025           London, UK
5        Healthcare                             3                 10/2019                 228                  31                                      10/2024           Various
6        Caravan Parks                          3                 02/2021                 225                  -                                       02/2028           Various, UK
7        Office                                 3                 06/2019                 207                  26                                      11/2026           Berlin, Germany
8        Office                                 3                 10/2018                 198                  2                                       01/2022           Manhattan, NY
9        Office                                 3                 01/2020                 198                  90                                      02/2025           Long Island City, NY
10       Industrial                             3                 01/2019                 197                  7                                       02/2024           Brooklyn, NY
11       Office                                 3                 09/2019                 192                  -                                       09/2023           London, UK
12       Industrial                             3                 03/2021                 185                 111                                      05/2026           Various
13       Hotel                                  3                 04/2018                 152                  -                                       04/2023           Honolulu, HI




                                       32

--------------------------------------------------------------------------------


14     Multifamily Development(1)                5        03/2017        152            -                       12/2021      Brooklyn, NY
15     Hotel                                     3        09/2015        145            -                       06/2024      Manhattan, NY
16     Office                                    3        10/2018        145           42            Y          10/2023      Manhattan, NY
17     Office                                    3        11/2017        144            -                       01/2023      Chicago, IL
18     Hotel                                     3        08/2019        140            -                       08/2024      Puglia, Italy
19     Office(2)                                 3        12/2017        121            -                       07/2022      London, UK
20     Urban Retail(1)                           5        01/2016        118            -                       09/2021      Miami, FL
21     Office                                    3        04/2019        117           42            Y          09/2025      Culver City, CA
22     Hotel                                     3        05/2018        115            -                       06/2023      Miami, FL
23     Retail center(1)                          5        11/2014        106            -                       09/2021      Cincinnati, OH
24     Hotel                                     3        03/2017        105            -                       03/2022      Atlanta, GA
25     Hotel                                     3        11/2018        100            -                       12/2023      Vail, CO
26     Residential-for-sale: inventory           3        12/2019        97             3                       01/2023      Boston, MA
27     Office                                    3        03/2018        92             -                       04/2023      Chicago, IL
28     Hotel                                     3        12/2017        82             -                       12/2023      Manhattan, NY
29     Mixed Use                                 3        12/2019        80             1                       12/2024      London, UK
30     Residential-for-sale: construction        3        12/2018        79            23            Y          01/2024      Hallandale Beach, FL
31     Residential-for-sale: construction        3        12/2018        71            107           Y          12/2023      Manhattan, NY
32     Residential-for-sale: inventory           3        01/2018        68             6                       01/2023      Manhattan, NY
33     Hotel                                     3        08/2019        67             -                       09/2022      Manhattan, NY
34     Residential-for-sale: construction        3        10/2015        66             -            Y          08/2021      Manhattan, NY
35     Hotel                                     3        04/2018        64             -                       05/2023      Scottsdale, AZ
36     Multifamily                               3        04/2014        63             -                       07/2023      Various
37     Hotel                                     3        09/2019        61             -                       10/2024      Miami, FL
38     Hotel                                     3        12/2019        60             -                       01/2025      Tucson, AZ
39     Multifamily                               3        11/2014        54             -                       11/2021      Various
40     Urban Predevelopment                      3        12/2016        52             -                       06/2022      Los Angeles, CA
41     Hotel                                     3        05/2019        52             -                       06/2024      Chicago, IL
42     Multifamily                               3        02/2020        50             1                       03/2024      Cleveland, OH
43     Hotel                                     3        12/2015        42             -                       08/2024      St. Thomas, USVI
44     Office                                    3        12/2019        37             2                       12/2022      Edinburgh, Scotland
45     Mixed Use                                 3        12/2019        25            829           Y          06/2025      London, UK
46     Hotel                                     3        02/2018        22             5                       11/2024      Pittsburgh, PA
47     Residential-for-sale: inventory           3        05/2018        18             -                       05/2021      Manhattan, NY
48     Residential-for-sale: inventory           3        06/2018        13             -                       07/2021      Manhattan, NY
       General CECL Allowance                                           (18)
       Sub total / Weighted-Average
       Commercial Mortgage Loans                3.1                    $5,754        $1,374                    2.9 Years



Subordinate Loan and Other Lending Assets Portfolio


   #                  Property Type               Risk Rating     

Origination Date Amortized Cost Unfunded Commitment Construction Loan Fully-extended Maturity

             Location
1        Residential-for-sale: construction(3)         3               06/2015               $226                     -                       Y                       06/2021            Manhattan, NY
2        Residential-for-sale: construction(3)         3               11/2017                153                     -                       Y                       06/2021            Manhattan, NY
3        Residential-for-sale: inventory(4)            3               12/2017                115                     7                                               06/2022            Manhattan, NY
4        Office                                        3               01/2019                100                     -                                               12/2025            Manhattan, NY
5        Residential-for-sale: construction            3               12/2017                79                      4                       Y                       04/2023            Los Angeles, CA
6        Healthcare(5)                                 3               01/2019                75                      -                                               01/2024            Various
7        Healthcare(6)                                 3               07/2019                51                      -                                               06/2024            Various
8        Mixed Use                                     3               01/2017                42                      -                                               02/2027            Cleveland, OH
9        Mixed Use                                     3               02/2019                40                      -                       Y                       12/2022            London, UK
10       Mixed Use                                     3               12/2018                34                     17                       Y                       12/2023            Brooklyn, NY
11       Industrial                                    2               05/2013                32                      -                                               05/2023            Various




                                       33

--------------------------------------------------------------------------------


12     Hotel(1)                           5        06/2015        28             -                       12/2022      Washington, DC
13     Hotel                              3        06/2015        24             -                       07/2025      Phoenix, AZ
14     Hotel                              3        06/2018        20             -                       06/2023      Las Vegas, NV
15     Multifamily                        3        05/2018        19             -                       05/2028      Cleveland, OH
16     Healthcare(5)(6)                   3        02/2019        17             -                       01/2034      Various
17     Office                             3        07/2013        14             -                       07/2022      Manhattan, NY
18     Office                             3        08/2017         8             -                       09/2024      Troy, MI
19     Mixed Use                          3        07/2012         7             -                       08/2022      Chapel Hill, NC
       General CECL Allowance                                    (18)
       Sub total / Weighted-Average
       Subordinate Loans and Other
       Lending Assets                    3.0                    $1,066          $28                     2.1 Years

       Total / Weighted-Average
       Loan Portfolio                    3.1                    $6,820        $1,402                    2.8 Years


-------


(1)Amortized cost for these loans is net of the recorded Specific CECL
Allowance.
(2)Includes $24.0 million of a subordinate participation sold accounted for as
secured borrowing.
(3)Both loans are secured by the same property.
(4)Includes $26.7 million of a subordinate participation sold accounted for as
secured borrowing.
(5)Loan and Single Asset, Single Borrower CMBS are secured by the same
properties.
(6)Single Asset, Single Borrower CMBS.

Our average asset and debt balances for the three months ended March 31, 2021 were ($ in thousands):


                                                   Average month-end 

balances for the three months ended


                                                                      March 31, 2021
Description                                                 Assets                     Related debt
Commercial mortgage loans, net                     $           5,815,991          $         3,500,539
Subordinate loans and other lending assets,
net                                                            1,083,394                            -


Portfolio Management
Due to the impact of COVID-19, some of our borrowers have experienced
consequences which are preventing the execution of their business plans and in
some cases temporary closures. As a result, we have worked with borrowers to
execute loan modifications which are typically coupled with additional equity
contributions from borrowers. Loan modifications to date have included
repurposing of reserves, temporary deferrals of interest or principal, and
partial deferral of coupon interest as payment-in-kind interest.
Investment Activity
During the three months ended March 31, 2021, we committed $527.7 million of
capital to loans ($417.2 million was funded at closing). In addition, during the
three months ended March 31, 2021, we received $232.0 million in repayments and
funded $133.4 million for loans closed prior to 2021.
Net Income (Loss) Available to Common Stockholders
For the three months ended March 31, 2021 and 2020, our net income (loss)
available to common stockholders was $55.0 million, or $0.37 per diluted share
of common stock, and $(131.2) million, or $(0.86) per diluted share of common
stock, respectively.
Operating Results
In connection with our adoption of the amendment to Item 303 of Regulation S-K,
we are changing our basis of comparison to compare the current period to the
previous period rather than the same period in the previous year. As this is the
first filing in which this change is made, we are providing both comparisons.
The reason for this change is because we believe comparing the most recent
period allows us to provide a more meaningful discussion to changes in operating
results given our business and target assets.
The following table sets forth information regarding our condensed consolidated
results of operations and certain key operating metrics compared to both the
same period in the previous year and the most recently reported period ($ in
thousands):


                                       34

--------------------------------------------------------------------------------


                                        Three months ended                  Q1'21 vs.                   Three months ended                  Q1'21 vs.
                                March 31, 2021         December 31,           Q4'20             March 31, 2021           March 31,            Q1'20
                                                           2020                                                            2020
Net interest income:
Interest income from          $        75,356          $   77,116          $  (1,760)         $        75,356          $   81,855          $  (6,499)
commercial mortgage loans
Interest income from
subordinate loans and other            31,459              22,944              8,515                   31,459              34,018             (2,559)
lending assets
Interest expense                      (35,664)            (35,364)              (300)                 (35,664)            (41,205)             5,541
Net interest income                    71,151              64,696              6,455                   71,151              74,668             (3,517)
Operating expenses:
General and administrative             (6,940)             (7,269)               329                   (6,940)             (6,531)              (409)

expenses


Management fees to related             (9,364)             (9,598)               234                   (9,364)            (10,268)               904
party
Total operating expenses              (16,304)            (16,867)               563                  (16,304)            (16,799)               495
Other income                               92                 125                (33)                      92                 760               (668)
Realized loss on investments                -             (30,190)            30,190                        -                   -                  -
Realized losses and
impairments on real estate               (550)                  -               (550)                    (550)                  -               (550)
owned
Reversal of (provision for)
loan losses - Specific CECL                 -              24,950            (24,950)                       -            (150,000)           150,000
Allowance, net
Reversal of (provision for)
loan losses - General CECL              1,238               1,404               (166)                   1,238             (33,465)            34,703
Allowance, net
Gain (loss) on foreign
currency forward contracts              9,800             (42,702)            52,502                    9,800              70,491            (60,691)
Foreign currency translation           (7,449)             35,304            (42,753)                  (7,449)            (37,949)            30,500
(gain) loss
Gain (loss) on interest rate              357                 (40)               397                      357             (35,548)            35,905
hedging instruments
Net income (loss)                        $58,335             $36,680            $21,655                  $58,335          $(127,842)           $186,177



Net Interest Income
Net interest income increased by $6.5 million during the three months ended
March 31, 2021 compared to the three months ended December 31, 2020. This
increase was primarily due to interest income on $417.2 million in originations
and $133.4 million of add on fundings during the three months ended March 31,
2021 and was partially offset by $174.8 million of full repayments and $57.2
million of partial repayments during the three months ended March 31, 2021 and a
$0.3 million increase in interest expense as a result of a $36.5 million
increase in our average debt balance during the three months ended March 31,
2021.
We recognized PIK interest of $16.8 million, and $10.3 million for the three
months ended March 31, 2021 and December 31, 2020, respectively.
We did not recognize any pre-payment penalties and accelerated fees for the
three months ended March 31, 2021 and December 31, 2020.
Net interest income decreased $3.5 million during the three months ended
March 31, 2021 compared to the three months ended March 31, 2020. This decrease
was primarily due to (i) three loans being placed on non-accrual at the end of
the first quarter in 2020 and (ii) 1.29% decrease in the average one-month LIBOR
for the three months ended March 31, 2021 compared to the three months ended
March 31, 2020. This decrease was partially offset by a $121.3 million decrease
in outstanding secured debt arrangements as of March 31, 2021 compared to March
31, 2020.
We recognized PIK interest of $16.8 million and $12.4 million for the three
months ended March 31, 2021 and 2020, respectively.


                                       35
--------------------------------------------------------------------------------

We did not recognize pre-payment penalties and accelerated fees for the three
months ended March 31, 2021. We recognized $0.2 million in pre-payment penalties
and accelerated fees for the three months ended March 31, 2020.
Operating Expenses
General and administrative expenses
General and administrative expenses decreased by $0.3 million for the three
months ended March 31, 2021 compared to the three months ended December 31,
2020. The decrease was primarily driven by a $0.6 million decrease in general
and administrative expenses offset by a $0.3 million increase in non-cash
restricted stock and RSU amortization related to shares of stock awarded under
the LTIPs.
General and administrative expenses increased by $0.4 million for the three
months ended March 31, 2021 compared to the three months ended March 31, 2020.
The increase was primarily driven by a $0.3 million increase in general and
administrative expenses and a $0.1 million increase in non-cash restricted stock
and RSU amortization related to shares of stock awarded under the LTIPs.
Management fees to related party
Management fee expense decreased by $0.2 million during the three months ended
March 31, 2021 as compared to the three months ended December 31, 2020. The
decrease is primarily attributable to the time weighted impact of a decrease in
our stockholders' equity (as defined in the Management Agreement) as a result of
our common stock repurchase of 3,998,037 shares during the fourth quarter of
2020.
Management fee expense decreased by $0.9 million during the three months ended
March 31, 2021 compared to the three months ended March 31, 2020. The decrease
is primarily attributable to a decrease in our stockholders' equity (as defined
in the Management Agreement) as a result of our common stock repurchase of
14,532,632 shares between April 2020 and December 2020.
Realized loss on investment
The loss for the three months ended December 31, 2020 is attributable to a $15.0
million realized loss in connection with a troubled debt restructuring, $11.0
million realized loss related to a loan recapitalization, $2.7 million realized
loss as a result of a loan sale and $2.4 million realized loss from a
foreclosure. There was no realized loss on investment during the three months
ended March 31, 2021 and 2020.
Impairment and realized losses on real estate owned
During the first quarter of 2021, the real estate owned asset was reviewed for
possible impairment due to a change in expected time to sell the asset. A $0.6
million impairment was recorded during the three months ended March 31, 2021.
Refer to "Note 5 - Real Estate Owned and Related Debt, Held for Sale" for more
information related to our impairment and realized losses on real estate owned.
There was no impairment or realized loss on real estate owned during the three
months ended December 31, 2020 and there was no real estate owned on our
condensed consolidated balance sheet as of March 31, 2020.
Reversal of (provision for) loan losses - General CECL Allowance, net
During the three months ended March 31, 2021, our General CECL Allowance
decreased by $1.2 million. The decrease is primarily related to the seasoning of
our loan portfolio and acceleration of expected repayments, which were partially
offset by new loan originations.
Our General CECL Allowance decreased $34.7 million for three months ended
March 31, 2021 compared to the three months ended March 31, 2020. This decrease
was largely due to improvement of economic conditions and seasoning of our loan
portfolio.
Refer to "Note 2 - Summary of Significant Accounting Policies" and "Note 4 -
Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for
additional information related to our General CECL Allowance.
Reversal of (provision for) loan losses - Specific CECL Allowance, net
During the three months ended December 31, 2020, we reversed $25.0 million of
previously recorded Specific CECL Allowances and impairments by realizing those
losses, which included $20.6 million on two mortgage loans, $1.4 million on one
subordinate loan, and $3.0 million on an equity position held in other assets in
our condensed consolidated balance sheet. Please see above for additional
information related to realized loss on investments.


                                       36
--------------------------------------------------------------------------------

During the three months ended March 31, 2020, we recorded impairments on five
new loans and increased the Specific CECL Allowance on two loans that previously
had loan loss provisions, primarily due to the impact from COVID-19.
There were no changes to the Specific CECL Allowance during the three months
ended March 31, 2021. Refer to "Note 4 - Commercial Mortgage, Subordinate Loans
and Other Lending Assets, Net" for additional information related to our
Specific CECL Allowance.
Foreign currency gain (loss) and gain (loss) on derivative instruments
We use forward currency contracts to economically hedge interest and principal
payments due under our loans denominated in currencies other than USD. When
foreign currency gain and (loss) on derivative instruments are evaluated on a
combined basis, the net impact for the three months ended March 31, 2021,
December 31, 2020, and March 31, 2020 was $2.4 million, $(7.4) million and $32.5
million, respectively.
Gain (loss) on interest rate hedges
In the second quarter of 2020, we entered into a three-year interest rate cap to
cap LIBOR at 0.75%. This effectively limits the maximum all-in coupon on our
2026 Term Loan to 3.50%. During the three months ended March 31, 2021 and
December 31, 2020, the interest rate cap had an unrealized gain (loss) of $0.4
million and $(40.0) thousand, respectively.
We previously used an interest rate swap to manage exposure to variable cash
flows on portions of our borrowings under our 2026 Term Loan. The interest rate
swap agreement allowed us to receive a variable rate cash flow based on LIBOR
and
pay a fixed rate cash flow. During the three months ended March 31, 2020 we had
an unrealized loss on the interest rate swap of $35.5 million. During the second
quarter of 2020, we terminated this interest rate swap.
Dividends
The following table details our dividend activity:
                                                 Three months ended
Dividends declared per share of:     March 31, 2021             March 31, 2020
Common Stock                              $0.35                      $0.40
Series B Preferred Stock                  0.50                       0.50


Subsequent Events
Refer to "Note 19 - Subsequent Events" to the accompanying condensed
consolidated financial statements for disclosure regarding significant
transactions that occurred subsequent to March 31, 2021.
Liquidity and Capital Resources
Liquidity is a measure of our ability to meet potential cash requirements,
including ongoing commitments to repay borrowings, fund and maintain our assets
and operations, make distributions to our stockholders and other general
business needs. As of March 31, 2021, we had $1.4 billion of corporate debt and
$3.4 billion of asset specific financings. We have no corporate debt maturities
until August 2022. As of March 31, 2021, we had $294 million of cash on hand and
$62.4 million of approved and undrawn capacity from our secured debt
arrangements. In addition, we have a significant amount of unencumbered loan
assets. In light of COVID-19 and its severe impact on the economy we have taken
steps to increase our cash balances in order to maintain an adequate level of
liquidity to meet future outflows. As the duration and severity of the COVID-19
pandemic, as well as the efficacy of the vaccines or other remedies and the
speed of their distribution and administration, remain unknown, so does the
impact it will have on our borrowers, lenders, and the economy as a whole. We
will continue to closely monitor developments related to COVID-19 as it relates
to our liquidity position and financial obligations. At this time we believe we
have the ability to generate and obtain adequate amounts of cash to meet
financial obligations. See "Contractual Obligations and Commitments" below for
further detail.
Debt-to-Equity Ratio
The following table presents our debt-to-equity ratio:
                                       March 31, 2021       December 31, 2020
           Debt to Equity Ratio (1)          1.9                   1.8


-------


                                       37

--------------------------------------------------------------------------------

(1)Represents total debt less cash and loan proceeds held by servicer (recorded
with Other Assets, see "Note 6 - Other Assets" for more information) to total
stockholders' equity.
Our primary sources of liquidity are as follows:
Cash Generated from Operations
Cash from operations is generally comprised of interest income from our
investments, net of any associated financing expense, principal repayments from
our investments, net of associated financing repayments, proceeds from the sale
of investments, and changes in working capital balances. See "Results of
Operations - Loan Portfolio Overview" above for a summary of interest rates
related to our investment portfolio as of March 31, 2021.
Borrowings Under Various Financing Arrangements
JPMorgan Facility
In November 2019, through three indirect wholly-owned subsidiaries, we entered
into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan
Chase Bank, National Association. The JPMorgan Facility allows for $1.3 billion
of maximum borrowings (with amounts borrowed in GBP and EUR converted to USD for
purposes of calculating availability based on the greater of the spot rate as of
the initial financing under the corresponding mortgage loan and the then-current
spot rate) and matures in June 2022 and has two one-year extensions available at
our option, which are subject to certain conditions. The JPMorgan Facility
enables us to elect to receive advances in USD, GBP, or EUR. Margin calls may
occur any time at specified aggregate margin deficit thresholds.
As of March 31, 2021, we had $1.1 billion (including £83.1 million and €60.0
million assuming conversion into USD) of borrowings outstanding under the
JPMorgan Facility secured by certain of our commercial mortgage loans.
DB Facility
In March 2020, through an indirect wholly-owned subsidiary, we entered into a
Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG,
Cayman Islands Branch, London Branch (the "DB Facility"). During the first
quarter 2021, we amended the DB Facility to reduce the commitment from $1.0
billion to $700.0 million ($425.8 million drawn at March 31, 2021) for the sale
and repurchase of eligible first mortgage loans secured by commercial or
multifamily properties, located in the United States, United Kingdom and the
European Union, and enables us to elect to receive advances in USD, GBP, or EUR.
The DB Facility matures in March 2022, and has a one-year extension available at
our option, subject to certain conditions. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
As of March 31, 2021, we had $425.8 million of borrowings outstanding under the
DB Facility secured by certain of our commercial mortgage loans.
Goldman Facility
In November 2017, through an indirect wholly-owned subsidiary, we entered into a
master repurchase and securities contract agreement with Goldman Sachs Bank USA,
which provides advances up to $500.0 million and matures in November 2021. In
addition, the Goldman Facility contains a two-year amortization period
subsequent to the November 2021 maturity, which allows for the refinancing or
pay down of assets under the facility. Margin calls may occur any time at
specified margin deficit thresholds.
As of March 31, 2021, we had $322.2 million of borrowings outstanding under the
Goldman Facility secured by certain of our commercial mortgage loans.
CS Facility - USD
In July 2018, through an indirect wholly-owned subsidiary, we entered into a
Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman
Islands Branch and Alpine Securitization Ltd, which provides for advances for
the sale and repurchase of eligible commercial mortgage loans secured by real
estate. The CS Facility - USD has an "evergreen" feature such that the facility
continues unless terminated at any time by Credit Suisse with six months'
notice. Margin calls may occur any time at specified aggregate margin deficit
thresholds.
As of March 31, 2021, we had $220.2 million of borrowings outstanding under the
CS Facility - USD secured by certain of our commercial mortgage loans.
HSBC Facility - EUR


                                       38
--------------------------------------------------------------------------------

In July 2019, through an indirect wholly-owned subsidiary, we entered into a
secured debt arrangement with HSBC Bank plc, which provides for a single asset
financing. The HSBC Facility - EUR was extended during the three months ended
March 31, 2021 and matures in July 2022. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
As of March 31, 2021, we had $157.3 million (€134.1 million assuming conversion
into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one
commercial mortgage loan.
Barclays Facility - USD
In March 2020, through an indirect wholly-owned subsidiary, we entered into a
secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays
Bank plc. The Barclays Facility - USD allows for $200.0 million of maximum
borrowings and initially matures in March 2023 with extensions available at our
option, subject to certain conditions. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
As of March 31, 2021, we had $35.2 million of borrowings outstanding under the
Barclays Facility - USD secured by one commercial mortgage loan.
Barclays Private Securitization
In June 2020, through a newly formed entity, we entered into a private
securitization with Barclays Bank plc, of which Barclays Bank plc retained
$782.0 million of senior notes. The Barclays Private Securitization finances the
loans that were previously financed under the Barclays Facility - GBP/EUR. In
June 2020, we pledged an additional commercial mortgage loan with an outstanding
principal balance of £26.0 million and pledged additional collateral of a
financed loan of €5.3 million as of June 30, 2020. During the quarter ended
March 31, 2021, we pledged two additional commercial mortgage loans with
outstanding principal balances of $227.4 million (£165.0 million assuming
conversion into USD) and $187.4 million (kr1.6 billion assuming conversion into
USD) as of March 31, 2021.
The Barclays Private Securitization eliminates daily margining provisions and
grants us significant discretion to modify certain terms of the underlying
collateral including waiving certain loan-level covenant breaches and deferring
or waiving of debt service payments for up to 18 months. The securitization
includes LTV based covenants with significant headroom to previous levels
included in the Barclays Facility - GBP/EUR. These deleveraging requirements are
based on significant declines in the value of the collateral as determined by an
annual third-party (engaged by us) appraisal process tied to the provisions of
the underlying loan agreements. We believe this provides us with both cushion
and predictability to avoid sudden unexpected outcomes and material repayment
requirements. In addition to the pledge of the additional collateral noted
above, we paid down the previous financing by €16.5 million (totaling $18.5
million in USD) and agreed to increase the financing spreads by 0.25%.
The table below provides the borrowings outstanding (on an as converted basis)
and weighted-average fully-extended maturities by currency for the assets
financed under the Barclays Private Securitization as of March 31, 2021 ($ in
thousands):
                                                                          Borrowings outstanding                  Fully-Extended Maturity(1)
Total/Weighted-Average GBP                                                                    $879,815                    July 2024
Total/Weighted-Average SEK                                                                     149,883                    March 2022
Total/Weighted-Average EUR                                                                     143,600                 February 2022(2)
Total/Weighted-Average Securitization                                                       $1,173,298                  December 2023


-------


(1)Assumes underlying loans extend to fully extended maturity and extensions at
our option are exercised.
(2)The EUR portion of the Barclays Private Securitization has an "evergreen"
feature such that the facility continues for one year and can be terminated by
either party on certain dates with, depending on the date of notice, a minimum
of nine to twelve months' notice.

As of March 31, 2021, we had $1.2 billion (£638.3 million, €122.4 million, and
kr1.3 billion assuming conversion into USD) of borrowings outstanding under the
Barclays Private Securitization secured by certain of our commercial mortgage
loans.
Debt Covenants
The guarantees related to our secured debt arrangements contain the following
financial covenants: (i) tangible net worth must be greater than $1.25 billion
plus 75% of the net cash proceeds of any equity issuance after March 31, 2017
(ii) our ratio of total indebtedness to tangible net worth cannot be greater
than 3.75:1; and (iii) our liquidity cannot be less than an amount equal to the
greater of 5% of total recourse indebtedness or $30.0 million. Under these
covenants, our General CECL Allowance is added back to our tangible net worth
calculation.


                                       39

--------------------------------------------------------------------------------

We were in compliance with the covenants under each of our secured debt
arrangements at March 31, 2021 and December 31, 2020.
Senior Secured Term Loan
In May 2019, we entered into the $500.0 million 2026 Term Loan. During the three
months ended March 31, 2021, we repaid $1.3 million of principal related to the
2026 Term Loan. The 2026 Term Loan bears interest at LIBOR plus 2.75%, was
issued at a price of 99.5%, and matures in May 2026.
In March 2021, we entered into the $300.0 million 2028 Term Loan. The 2028 Term
Loan bears interest at LIBOR (with a floor of 0.50%) plus 3.50%, was issued at a
price of 99.0%, and matures in March 2028.
The outstanding Term Loans principal balance as of March 31, 2021 and
December 31, 2020 was $791.3 million and $492.5 million, respectively. The Term
Loans contain restrictions relating to liens, asset sales, indebtedness, and
investments in non-wholly owned entities. The Term Loans include the following
financial covenants: (i) our ratio of total recourse debt to tangible net worth
cannot be greater than 3:1; and (ii) our ratio of total unencumbered assets to
total pari-passu indebtedness must be at least 1.25:1.
Convertible Senior Notes
In two separate offerings during 2017, we issued an aggregate principal amount
of $345.0 million of 4.75% Convertible Senior Notes due 2022, for which we
received $337.5 million, after deducting the underwriting discount and offering
expenses. At March 31, 2021, the 2022 Notes had a carrying value of $341.0
million and an unamortized discount of $4.0 million.
During the fourth quarter of 2018, we issued $230.0 million of 5.375%
Convertible Senior Notes due 2023, for which we received $223.7 million after
deducting the underwriting discount and offering expenses. At March 31, 2021,
the 2023 Notes had a carrying value of $225.7 million and an unamortized
discount of $4.3 million.
Other Potential Sources of Financing
Our primary sources of cash currently consist of cash available, which was
$294.1 million as of March 31, 2021, principal and interest payments we receive
on our portfolio of assets, and available borrowings under our secured debt
arrangements. We expect our other sources of cash to consist of cash generated
from operations and prepayments of principal received on our portfolio of
assets. Such prepayments are difficult to estimate in advance. Depending on
market conditions, we may utilize additional borrowings as a source of cash,
which may also include additional secured debt arrangements as well as other
borrowings or conduct additional public and private debt and equity offerings.
As of March 31, 2021 we also held $1.5 billion of unencumbered assets,
consisting of $428.9 million of senior mortgages and $1.1 billion of mezzanine
loans.
We maintain policies relating to our borrowings and use of leverage. See
"Leverage Policies" below. In the future, we may seek to raise further equity or
debt capital or engage in other forms of borrowings in order to fund future
investments or to refinance expiring indebtedness.
We generally intend to hold our target assets as long-term investments, although
we may sell certain of our investments in order to manage our interest rate risk
and liquidity needs, meet other operating objectives and adapt to market
conditions.
To maintain our qualification as a REIT under the Internal Revenue Code, we must
distribute annually at least 90% of our REIT taxable income, determined without
regard to the deduction for dividends paid and excluding net capital gain. These
distribution requirements limit our ability to retain earnings and replenish or
increase capital for operations.
Leverage Policies
We use leverage for the sole purpose of financing our portfolio and not for the
purpose of speculating on changes in interest rates. In addition to our secured
debt arrangements and senior secured term loan, we access additional sources of
borrowings. Our charter and bylaws do not limit the amount of indebtedness we
can incur; however, we are subject to and carefully monitor the limits placed on
us by our credit providers and those that assign ratings on our Company.
At March 31, 2021, our debt-to-equity ratio was 1.9 and our portfolio was
comprised of $5.8 billion of commercial mortgage loans and $1.1 billion of
subordinate loans and other lending assets. In order to achieve our return on
equity, we generally finance our mortgage loans with 2.0 to 3.0 turns of
leverage and generally do not finance our subordinate loan portfolio given
built-in inherent structural leverage. Consequently, depending on our portfolio
mix, our debt-to-equity ratio may exceed our previously disclosed thresholds.


                                       40
--------------------------------------------------------------------------------

Investment Guidelines
Our current investment guidelines, approved by our board of directors, are
comprised of the following:
•no investment will be made that would cause us to fail to qualify as a REIT for
U.S. federal income tax purposes;
•no investment will be made that would cause us to register as an investment
company under the 1940 Act;
•investments will be predominantly in our target assets;
•no more than 20% of our cash equity (on a consolidated basis) will be invested
in any single investment at the time of the investment; and
•until appropriate investments can be identified, the Manager may invest the
proceeds of any offering in interest bearing, short-term investments, including
money market accounts and/or funds, that are consistent with our intention to
qualify as a REIT.
The board of directors must approve any change in or waiver to these investment
guidelines.
Contractual Obligations and Commitments
Our contractual obligations including expected interest payments as of March 31,
2021 are summarized as follows ($ in thousands):

                                                                                                                                              More
                                                  Less than 1                                       2 to 3               3 to 5              than 5
                                                    year (1)            1 to 2 years(1)           years (1)            years (1)           years (1)             Total
Secured debt arrangements(1)(2)                  $   823,510          $     

461,075 $ 1,212,425 $ 1,103,703 $ -

$ 3,600,713
Senior secured term loan(2)                           36,286                    35,938               35,660               70,138            764,239    

942,261


Convertible senior notes                              28,750                   363,978              237,211                    -                  -     

629,939


Unfunded loan commitments (3)                        692,202                   423,524              275,416                2,387                  -            1,393,529
Total                                            $ 1,580,748          $      1,284,515          $ 1,760,712          $ 1,176,228          $ 764,239          $ 6,566,442


-------
(1)   Assumes underlying assets are financed through the fully extended maturity
date of the secured debt arrangement.
(2)   Based on the applicable benchmark rates as of March 31, 2021 on the
floating rate debt for interest payments due.
(3)   Based on fully extended maturity and our expected funding schedule, which
is based upon the Manager's estimates based upon the best information available
to the Manager at the time. There is no assurance that the payments will occur
in accordance with these estimates or at all, which could affect our operating
results. Refer to "Note 16 - Commitments and Contingencies" for further detail
regarding unfunded loan commitments.

Loan Commitments. As of March 31, 2021, we had $1.4 billion of unfunded loan
commitments, comprised of $1.4 billion related to our commercial mortgage loan
portfolio, and $28.5 million related to our subordinate loan portfolio.
Management Agreement. On September 23, 2009, we entered into the Management
Agreement with the Manager pursuant to which the Manager is entitled to receive
a management fee and the reimbursement of certain expenses. The table above does
not include amounts due under the Management Agreement as those obligations do
not have fixed and determinable payments. Pursuant to the Management Agreement,
the Manager is entitled to a base management fee calculated and payable
quarterly in arrears in an amount equal to 1.5% of our stockholders' equity (as
defined in the Management Agreement), per annum. The Manager will use the
proceeds from its management fee in part to pay compensation to its officers and
personnel. We do not reimburse the Manager or its affiliates for the salaries
and other compensation of their personnel, except for the allocable share of the
compensation of (1) our Chief Financial Officer based on the percentage of time
spent on our affairs and (2) other corporate finance, tax, accounting, internal
audit, legal, risk management, operations, compliance and other non-investment
professional personnel of the Manager or its affiliates who spend all or a
portion of their time managing our affairs based on the percentage of time
devoted by such personnel to our affairs. We are also required to reimburse the
Manager for operating expenses related to us incurred by the Manager, including
expenses relating to legal, accounting, due diligence and other services.
Expense reimbursements to the Manager are made in cash on a monthly basis
following the end of each month. Our reimbursement obligation is not subject to
any dollar limitation.
The current term of the Management Agreement will expire on September 29, 2021.
Absent certain action by the independent directors of our board of directors, as
described below, the Management Agreement will automatically renew on each
anniversary for a one-year term. The Management Agreement may be terminated upon
expiration of the one-year term only upon the affirmative vote of at least
two-thirds of our independent directors, based upon (1) unsatisfactory
performance by the Manager that is materially detrimental to us or (2) a
determination that the management fee payable to the Manager is not


                                       41
--------------------------------------------------------------------------------

fair, subject to the Manager's right to prevent such a termination based on
unfair fees by accepting a mutually acceptable reduction of management fees
agreed to by at least two-thirds of our independent directors. The Manager must
be provided with written notice of any such termination at least 180 days prior
to the expiration of the then existing term and will be paid a termination fee
equal to three times the sum of the average annual base management fee during
the 24-month period immediately preceding the date of termination, calculated as
of the end of the most recently completed fiscal quarter prior to the date of
termination. Amounts payable under the Management Agreement are not fixed and
determinable. Following a meeting by our independent directors in February 2021,
which included a discussion of the Manager's performance and the level of the
management fees thereunder, we determined not to terminate the Management
Agreement.
Forward Currency Contracts. We use forward currency contracts to economically
hedge interest and principal payments due under our loans denominated in
currencies other than USD. We have entered into a series of forward contracts to
sell an amount of foreign currency (GBP, SEK and EUR) for an agreed upon amount
of USD at various dates through May 2026. These forward contracts were executed
to economically fix the USD amounts of foreign denominated cash flows expected
to be received by us related to foreign denominated loan investments. Refer to
"Note 10- Derivatives, Net" to the accompanying condensed consolidated financial
statements for details regarding our forward currency contracts.
Interest Rate Cap. In June 2020, we entered into an interest rate cap for
approximately $1.1 million. We use our interest rate cap to manage exposure to
variable cash flows on our borrowings under our senior secured term loan by
effectively limiting LIBOR from exceeding 0.75%. Refer to "Note 10- Derivatives,
Net" to the accompanying condensed consolidated financial statements for details
regarding our interest rate cap.
Off-balance Sheet Arrangements
As of March 31, 2021, we have interests in two unconsolidated joint ventures,
each of which owns underlying properties that secure one of our first mortgage
loans, respectively. The unconsolidated joint ventures were deemed to be VIEs,
of which we are not the primary beneficiary. Accordingly, the VIEs are not
consolidated in our condensed consolidated financial statements as of March 31,
2021. Our maximum exposure to loss from these commercial mortgage loans is
limited to their carrying value, which as of March 31, 2021 was $224.0 million.
Dividends
We intend to continue to make regular quarterly distributions to holders of our
common stock. U.S. federal income tax law generally requires that a REIT
distribute annually at least 90% of our REIT taxable income, without regard to
the deduction for dividends paid and excluding net capital gains, and that we
pay tax at regular corporate rates to the extent that we annually distribute
less than 100% of our net taxable income. We generally intend over time to pay
dividends to our stockholders in an amount equal to our net taxable income, if
and to the extent authorized by our board of directors. Any distributions we
make are at the discretion of our board of directors and depend upon, among
other things, our actual results of operations. These results and our ability to
pay distributions are affected by various factors, including the net interest
and other income from our portfolio, our operating expenses and any other
expenditures. If our cash available for distribution is less than our net
taxable income, we could be required to sell assets or borrow funds to make cash
distributions or we may make a portion of the required distribution in the form
of a taxable stock distribution or distribution of debt securities.
As of March 31, 2021, we had 6,770,393 shares of Series B Preferred Stock
outstanding, which entitles holders to receive dividends that are payable
quarterly in arrears. The Series B Preferred Stock pay cumulative cash
dividends, which are payable quarterly in equal amounts in arrears on the 15th
day of each January, April, July and October: (i) from, and including, the
original date of issuance of the Series B Preferred Stock to, but
excluding, September 20, 2020, at an initial rate of 8.00% per annum of
the $25.00 per share liquidation preference; and (ii) from, and
including, September 20, 2020, at the rate per annum equal to the greater of (a)
8.00% and (b) a floating rate equal to the 3-month LIBOR rate as calculated on
each applicable date of determination plus 6.46% of the $25.00 liquidation
preference. Except under certain limited circumstances, the Series B Preferred
Stock is generally not convertible into or exchangeable for any other property
or any other of our securities at the election of the holders. We may, at our
option, redeem the shares at a redemption price of $25.00, plus any accrued
unpaid distribution through the date of the redemption.
Non-GAAP Financial Measures
Distributable Earnings
Beginning in the fourth quarter of 2020 to more appropriately reflect the
principal purpose of the measure, "Operating Earnings" was relabeled
"Distributable Earnings", a non-GAAP financial measure. The definition continues
to be net income (loss) available to common stockholders, computed in accordance
with GAAP, adjusted for (i) equity-based compensation expense (a portion of
which may become cash-based upon final vesting and settlement of awards should
the holder elect net share settlement to satisfy income tax withholding),
(ii) any unrealized gains or losses or other non-cash items included in net


                                       42
--------------------------------------------------------------------------------

income available to common stockholders, (iii) unrealized income from
unconsolidated joint ventures, (iv) foreign currency gains (losses), other than
(a) realized gains/(losses) related to interest income, and (b) forward point
gains/(losses) realized on our foreign currency hedges, (v) the non-cash
amortization expense related to the reclassification of a portion of the Notes
to stockholders' equity in accordance with GAAP, and (vi) provision for loan
losses. Distributable Earnings may also be adjusted to exclude certain other
non-cash items, as determined by the Manager and approved by a majority of our
independent directors. For the three months ended March 31, 2021 and 2020, our
Distributable Earnings were $56.1 million, or $0.39 per share, and $62.7
million, or $0.40 per share, respectively.
The weighted-average diluted shares outstanding used for Distributable Earnings
per weighted-average diluted share has been adjusted from weighted-average
diluted shares under GAAP to exclude shares issued from a potential conversion
of the Notes. Consistent with the treatment of other unrealized adjustments to
Distributable Earnings, these potentially issuable shares are excluded until a
conversion occurs, which we believe is a useful presentation for investors. We
believe that excluding shares issued in connection with a potential conversion
of the Notes from our computation of Distributable Earnings per weighted average
diluted share is useful to investors for various reasons, including the
following: (i) conversion of Notes to shares requires both the holder of a Note
to elect to convert the Note and for us to elect to settle the conversion in the
form of shares (ii) future conversion decisions by Note holders will be based on
our stock price in the future, which is presently not determinable; (iii) the
exclusion of shares issued in connection with a potential conversion of the
Notes from the computation of Distributable Earnings per weighted-average
diluted share is consistent with how we treat other unrealized items in our
computation of Distributable Earnings per weighted-average diluted share; and
(iv) we believe that when evaluating our operating performance, investors and
potential investors consider our Distributable Earnings relative to our actual
distributions, which are based on shares outstanding and not shares that might
be issued in the future. For the three months ended March 31, 2020, 28,533,271
weighted-average potentially issuable shares with respect to the Notes were
excluded from weighted-average diluted shares outstanding because the effect was
anti-dilutive (see "Note 18- Net Income (Loss) per Share" for additional
information).
The table below summarizes the reconciliation from weighted-average diluted
shares under GAAP to the weighted-average diluted shares used for Distributable
Earnings ($ in thousands, except Price):
                                                                                             Three months ended March 31,
                                                                                       2021                                   2020
Weighted-Averages                                                                     Shares                                 Shares
Diluted shares - GAAP                                                                170,792,684                            153,948,191
Potential shares issued under conversion of the Notes                                (28,533,271)                                     -
Unvested RSUs                                                                                  -                              2,007,242
Diluted shares - Distributable Earnings                                              142,259,413                            155,955,433



As a REIT, U.S. federal income tax law generally requires us to distribute
annually at least 90% of our REIT taxable income, without regard to the
deduction for dividends paid and excluding net capital gains, and that we pay
tax at regular corporate rates to the extent that we annually distribute less
than 100% of our net taxable income. Given these requirements and our belief
that dividends are generally one of the principal reasons stockholders invest in
a REIT, we generally intend over time to pay dividends to our stockholders in an
amount equal to our net taxable income, if and to the extent authorized by our
board of directors. Distributable Earnings is a key factor considered by the
board of directors in setting the dividend and as such we believe Distributable
Earnings is useful to investors.
As discussed in "Note 10 - Derivatives" we terminated our interest rate swap,
which we used to manage exposure to variable cash flows on our borrowings under
our senior secured term loan, in the second quarter of 2020 and recorded a
realized loss in our condensed consolidated statement of operations. We have not
had an interest rate swap on our condensed consolidated balance sheet since this
termination. In addition, as discussed in "Note 4 - Commercial Mortgage,
Subordinate Loans and Other Lending Assets, Net," we recorded a net realized
loss on the sale of seven of our commercial real estate loans, two
restructurings, one payoff of a previously impaired loan, and one foreclosure.
We also believe it is useful to our investors to present Distributable Earnings
prior to realized losses and impairments on real estate owned to reflect our
operating results because (i) our operating results are primarily comprised of
earning interest income on our investments net of borrowing and administrative
costs, which comprise our ongoing operations and (ii) it has been a useful
factor related to our dividend per share because it is one of the considerations
when a dividend is determined. We believe that our investors use Distributable
Earnings and Distributable Earnings prior to realized losses and impairments on
real estate owned, or a comparable supplemental performance measure, to evaluate
and compare the performance of our company and our peers.


                                       43
--------------------------------------------------------------------------------

A significant limitation associated with Distributable Earnings as a measure of
our financial performance over any period is that it excludes unrealized gains
(losses) from investments. In addition, our presentation of Distributable
Earnings may not be comparable to similarly-titled measures of other companies,
that use different calculations. As a result, Distributable Earnings should not
be considered as a substitute for our GAAP net income as a measure of our
financial performance or any measure of our liquidity under GAAP. Distributable
Earnings are reduced for realized losses on loans which include losses that
management believes are near certain to be realized.
The table below summarizes the reconciliation from net income available to
common stockholders to Distributable Earnings and Distributable Earnings prior
to realized losses and impairments on real estate owned ($ in thousands):
                                                                    Three 

Months Ended March 31,


                                                                  2021                         2020
Net income (loss) available to common stockholders       $            54,950          $          (131,227)
Adjustments:
Equity-based compensation expense                                      4,387                        4,263
Unrealized loss on interest rate swap                                      -                       35,548
Gain on foreign currency forwards                                     (9,800)                     (70,491)
Foreign currency loss, net                                             7,449                       37,949
Unrealized gain on interest rate cap                                    (357)                           -
Realized gains (losses) relating to interest income on                  (620)                         256
foreign currency hedges, net
Realized gains relating to forward points on foreign                       6                        2,171
currency hedges, net
Amortization of the convertible senior notes related to                  800                          754
equity reclassification
Provision for (reversal of) loan losses and impairments               (1,238)                     183,465
Total adjustments:                                                       627                      193,915
Distributable Earnings prior to realized losses and      $            55,577          $            62,688

impairments on real estate owned



Realized losses and impairments on real estate owned                     550                            -
Distributable Earnings                                   $            56,127          $            62,688
Diluted Distributable Earnings per share prior to        $              0.39          $              0.40

realized losses and impairments on real estate owned Diluted Distributable Earnings per share of common stock $

              0.39          $              0.40

Weighted-average diluted shares - Distributable Earnings 142,259,413

                  155,955,433



Book Value Per Share

The table below calculates our book value per share ($ in thousands, except per
share data):
                                                       March 31, 2021             December 31, 2020
Stockholders' Equity                               $         2,275,753          $         2,270,529
   Series B Preferred Stock (Liquidation
Preference)                                                   (169,260)                    (169,260)
Common Stockholders' Equity                        $         2,106,493          $         2,101,269
Common Stock                                               139,848,875                  139,295,867
Book value per share                               $             15.06          $             15.08


The table below shows the changes in our book value per share:


                                       44
--------------------------------------------------------------------------------

                                                                         Book value per share
Book value per share at December 31, 2020                              $               15.08

General CECL Allowance                                                                  0.30

Book value per share at December 31, 2020 prior to General CECL Allowance

                                                              $               15.38
Earnings in excess of dividends                                                         0.04
Net unrealized gain on currency hedges                                                  0.02
Vesting and delivery of RSUs                                                           (0.08)
Other                                                                                  (0.01)

Book value per share at March 31, 2021 prior to General CECL Allowance $

            15.35
General CECL Allowance                                                 $               (0.29)
Book value per share at March 31, 2021                                 $               15.06



We believe that presenting book value per share with sub-totals prior to the
CECL Allowances is useful for investors for various reasons, including, among
other things, analyzing our compliance with financial covenants related to
tangible net worth and debt-to-equity under our secured debt arrangements and
senior secured term loan, which permit us to add the General CECL Allowance to
our GAAP stockholders' equity. Given that our lenders consider book value per
share prior to the General CECL Allowance as an important metric related to our
debt covenants, we believe disclosing book value per share prior to the General
CECL Allowance is important to investors such that they have the same
visibility.


                                       45

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses